Treat-to-target means adjusting urate-lowering therapy using repeated serum urate measurements until a defined target is reached. NICE recommends starting with a low dose and using monthly serum urate measurements to guide dose increases as tolerated.
Read the primary guidance/source →
General educational information, not individual medical advice. Evidence reviewed September 2026.
